In a report released yesterday, Umer Raffat from Evercore ISI maintained a Buy rating on Merck & Company (MRK – Research Report). The company’s shares closed yesterday at $89.67. Leverage the ...

Start 2025 with better oral health. Learn how a healthier smile boosts confidence and well-being with expert dental care tips for the new year. MIAMI, FL, UNITED ...

On Tuesday, Merck & Co Inc (NYSE:MRK) reported fourth-quarter sales of $15.62 billion, up 7% year over year and slightly beating the consensus estimate of $15.49 billion. Excluding the impact of ...

However, on the same day, Bank of America Securities maintained a Buy rating on Merck & Company (NYSE: MRK). The company has a one-year high of $134.63 and a one-year low of $87.33. Currently ...

In Canada, Merck markets a broad range of vaccines, pharmaceutical and animal health products and is one of the top R&D investors in Canada, with investments totaling more than $90 million in 2022 and ...

Below is an image shared on the Nike SNKRS app yesterday that broke down the NBHD doors stocking the limited “Bred” Air Jordan 1 High ’85 next month. A majority of the shops are located in ...

RAHWAY, N.J., January 28, 2025--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD ... the impact of pharmaceutical industry regulation and health care legislation in the United States and ...

Merck (MRK) announced that the board of directors has declared a quarterly dividend of 81c per share of the company’s common stock for the second quarter of 2025. Payment will be made on April 7 ...

Merck MRK will report its fourth-quarter and full-year 2024 earnings on Feb. 4, before market open. The Zacks Consensus Estimate for sales and earnings is pegged at $15.56 billion and $1.72 per ...

Citi lowered the firm’s price target on Merck (MRK) to $125 from $130 and keeps a Buy rating on the shares. Ahead of the Q4 earnings, the firm updated models for its biotechnology and ...